使用Penumbra SMART COIL系统治疗动静脉瘘的临床结局:多中心SMART注册研究的亚组分析
该研究为SMART注册研究的亚组分析,纳入41例接受Penumbra SMART COIL系统血管内栓塞治疗的动静脉瘘患者,随访12±6个月。结果显示术后完全闭塞率87.8%,围手术期严重不良事件率2.4%,1年时93.3%患者病变闭塞改善或稳定。作者认为该系统在1年随访时安全有效。
要点
- 41例动静脉瘘患者接受SMART COIL系统栓塞,术后完全闭塞率87.8%(36/41)。
- 围手术期严重不良事件率2.4%(1/41),无围手术期死亡(0/41)。
- 1年时93.3%(28/30)患者病变闭塞改善或稳定,全因死亡率2.4%(1/41)。
核心结论
- 使用SMART COIL系统对动静脉瘘进行栓塞治疗在1年随访时被证明安全有效。
研究设计与样本
- SMART注册研究是一项上市后、前瞻性、多中心、单臂设计的注册研究,本分析为其亚组分析。
- 纳入接受Penumbra SMART COIL系统血管内栓塞治疗的动静脉瘘患者,共41例。
- 治疗后对患者进行12±6个月的监测。
主要发现
- 无患者(0/41)发生器械相关严重不良事件。
- 85.4%(35/41)的患者无需因导管踢出而使用导丝重新进入。
- 术后完全闭塞达87.8%(36/41)。
- 围手术期严重不良事件率为2.4%(1/41),无围手术期死亡(0/41)。
- 随访期间再治疗率为3.4%(1/29),1年时病变闭塞改善或稳定为93.3%(28/30),术后24小时至1年(±6个月)严重不良事件率为26.8%(11/41),1年全因死亡率为2.4%(1/41),1年随访时90.9%(20/22)患者改良Rankin量表评分为0至2分。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular embolization procedures are typically the primary treatment modality for arteriovenous fistula (AVF). The objective of this subset analysis was to evaluate the prospective long-term clinical outcomes of AVF patients treated with the SMART COIL System. METHODS: Patients who had AVFs and underwent endovascular coiling using the Penumbra SMART COIL system were part of a subset analysis within the SMART registry. The SMART registry is a postmarket registry that is prospective, multicenter, and single-arm in design. After the treatment, these patients were monitored for a period of 12 ± 6 months. RESULTS: A total of 41 patients were included. No patients (0/41) had a procedural device-related serious adverse event (SAE). Reaccess involving a guidewire due to catheter kickout was unnecessary for 85.4% (35/41) of the patients. Complete occlusion after the procedure was achieved in 87.8% (36/41) of patients. The periprocedural SAE rate was 2.4% (1/41), and no periprocedural deaths occurred (0/41). During the follow-up period, there were instances of retreatment in 3.4% (1/29) of patients. At 1 year, the lesion occlusion was better or stable in 93.3% (28/30) of patients. The rate of SAE from 24 hours to 1 year (±6 months) following the procedure was 26.8% (11/41). The 1-year all-cause mortality rate stood at 2.4% (1/41), and at the 1-year follow-up, 90.9% (20/22) of patients had a modified Rankin Scale score within the range of 0 to 2. CONCLUSIONS: The coiling procedure for AVFs using the SMART COIL System proved to be safe and effective at the 1-year follow-up.
引用
- Abdelsalam A, Silva M, Park MS, et al. Clinical Outcomes of Arteriovenous Fistula Treatment Using the Penumbra SMART COIL System: A Subgroup Analysis from the Multicenter SMART Registry. World Neurosurg. 2024. PMID: 38986948. doi:10.1016/j.wneu.2024.07.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。